TTNP

Titan Pharmaceuticals
TTNP

Overview Fund Trends Analyst Outlook
Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

39 hedge funds and large institutions have $14.3M invested in Titan Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+24
Holders Change %
+160%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
7
Reduced
2
Closed
1
Calls
$1.91M
Puts
$311K
Net Calls
+$1.6M
Net Calls Change
+$312K

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$2.67M
2
State Street
State Street
Massachusetts
+$1.63M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.46M
4
Northern Trust
Northern Trust
Illinois
+$912K
5
BIT
BlackRock Institutional Trust
California
+$717K

Top Sellers

1
SIM
Spark Investment Management
New York
-$280K
2
DADC
D.A. Davidson & Co
Montana
-$144K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$26K
4
UBS Group
UBS Group
Switzerland
-$2K
Name Holding Trade Value Shares
Change 		Shares
Change %
AG
51
Advisor Group
Arizona
$2K – – –
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
– -$26K -2 Closed
1 2
3